MX2010004859A - Nueva composicion para tratar los efectos secundarios del tratamiento anticanceroso. - Google Patents

Nueva composicion para tratar los efectos secundarios del tratamiento anticanceroso.

Info

Publication number
MX2010004859A
MX2010004859A MX2010004859A MX2010004859A MX2010004859A MX 2010004859 A MX2010004859 A MX 2010004859A MX 2010004859 A MX2010004859 A MX 2010004859A MX 2010004859 A MX2010004859 A MX 2010004859A MX 2010004859 A MX2010004859 A MX 2010004859A
Authority
MX
Mexico
Prior art keywords
treating
side effects
anticancer treatments
novel composition
anticancer
Prior art date
Application number
MX2010004859A
Other languages
English (en)
Inventor
Thierry Bordet
Rebecca Pruss
Jean-Louis Abitbol
Antoine Beret
Original Assignee
Trophos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trophos filed Critical Trophos
Publication of MX2010004859A publication Critical patent/MX2010004859A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se refiere a nuevas composiciones, en particular, composiciones farmacéuticas, que contienen como agentes activos, por lo menos un agente citotóxico y, al menos un derivado de oxima de colest-4-en-3-ona, para tratar los efectos secundarios de tratamientos anticancerosos.
MX2010004859A 2007-10-30 2008-10-30 Nueva composicion para tratar los efectos secundarios del tratamiento anticanceroso. MX2010004859A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0707625 2007-10-30
PCT/FR2008/001528 WO2009092892A2 (fr) 2007-10-30 2008-10-30 Nouvelle composition pour traiter les effets secondaires des traitements anticancereux

Publications (1)

Publication Number Publication Date
MX2010004859A true MX2010004859A (es) 2010-06-21

Family

ID=40791126

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004859A MX2010004859A (es) 2007-10-30 2008-10-30 Nueva composicion para tratar los efectos secundarios del tratamiento anticanceroso.

Country Status (10)

Country Link
US (1) US20100310674A1 (es)
EP (1) EP2214789A2 (es)
JP (1) JP2011502112A (es)
AU (1) AU2008348717B2 (es)
CA (1) CA2704128A1 (es)
MX (1) MX2010004859A (es)
NZ (1) NZ584849A (es)
RU (1) RU2485956C2 (es)
WO (1) WO2009092892A2 (es)
ZA (1) ZA201002576B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2874923B1 (fr) * 2004-09-07 2006-10-27 Trophos Sa Application a titre de medicaments de derives du 3, 5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant, nouveaux derives et leur procede de preparation
FR2919180B1 (fr) * 2007-07-25 2009-11-27 Trophos Utilisation d'au moins un derive oxime de la cholest-4-en-3-one comme antioxydants
EP2701700A4 (en) * 2011-04-27 2015-10-21 Univ Yale Inc PHARMACEUTICAL THERAPY FOR INHIBITING CHEMOTHERAPY-INDUCED SIDE EFFECTS AND CORRESPONDING PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING METHOD AND KITS
FR2979239A1 (fr) 2011-08-25 2013-03-01 Trophos Liposome comprenant au moins un derive de cholesterol

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3482418B2 (ja) * 1991-07-26 2003-12-22 ライフ技研株式会社 細胞障害性制癌剤の副作用軽減および制癌作用増強剤
HU9701081D0 (en) * 1997-06-23 1997-08-28 Gene Research Lab Inc N Pharmaceutical composition of antitumoral activity
US20030199535A1 (en) * 1998-07-30 2003-10-23 Claudio Cavazza Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent
PT1601363E (pt) * 2003-03-11 2012-08-17 Trophos Aplicação como medicamentos de derivados da colest-4-en-3- ona, composições farmacêuticas que os contêm e novos derivados
FR2894968B1 (fr) * 2005-12-20 2008-02-22 Trophos Sa Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation
FR2898272B1 (fr) * 2006-03-09 2008-07-04 Trophos Sa Utilisation de derives du 3,5-seco-4-nor-cholestrane pour l'obtention d'un medicament cytoprotecteur
FR2899108B1 (fr) * 2006-03-31 2012-02-03 Trophos Utilisation de derives du cholest-4-en-3-one pour l'obtention d'un medicament cytoprotecteur

Also Published As

Publication number Publication date
WO2009092892A2 (fr) 2009-07-30
EP2214789A2 (fr) 2010-08-11
RU2485956C2 (ru) 2013-06-27
CA2704128A1 (fr) 2009-07-30
AU2008348717A1 (en) 2009-07-30
NZ584849A (en) 2012-04-27
WO2009092892A3 (fr) 2009-09-17
RU2010121882A (ru) 2011-12-10
US20100310674A1 (en) 2010-12-09
JP2011502112A (ja) 2011-01-20
AU2008348717B2 (en) 2013-09-19
ZA201002576B (en) 2011-03-30

Similar Documents

Publication Publication Date Title
MX2009009948A (es) Derivados de piridazinona utiles como inhibidores de glucano sintasa.
HK1133787A1 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
IN2012DN01233A (es)
ATE510538T1 (de) Zusammensetzungen und verfahren für nervenschutz
WO2008097640A8 (en) Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
WO2012065958A9 (en) Method of treating contrast-induced nephropathy
MX2007008790A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso.
NZ577916A (en) Cyclopamine analogs
MX2009010170A (es) Formulaciones topicas que tienen biodisponibilidad aumentada.
WO2012103038A3 (en) Nanoparticle compositions, formulations thereof, and uses therefor
UA103614C2 (uk) Лікарський засіб, що містить комбінацію інгібітора кінази та анти-гліпікан 3-антитіла, для лікування раку печінки
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
UA103181C2 (ru) Соединения, которые ингибируют дипептидилпептидазу-iv и фармацевтическая композиция, которая содержит их как активный агент
MX2010007677A (es) Derivados de hidroximoil-tetrazol como fungicidas.
WO2011087548A3 (en) Therapeutic compositions and methods for targeted delivery of active agents
JO2721B1 (en) Derivatives of artemisia plant and its preparations and therapeutic applications
WO2008011173A3 (en) Improvement of arginase levels/activity
HK1154777A1 (en) Lipoprotein lipase-activating compositions comprising benzene derivatives
WO2010121164A3 (en) 1,4-benzodiazepinone compounds and their use in treating cancer
WO2009019708A3 (en) Pharmaceutical compositions and methods for the treatment of cancer
MX2010004859A (es) Nueva composicion para tratar los efectos secundarios del tratamiento anticanceroso.
ZA201008160B (en) Compositions for the treatment of hair loss

Legal Events

Date Code Title Description
FA Abandonment or withdrawal